Virus puts damper on R&D

One more victim of COVID-19 may be innovation. Although a number of privately- and federally-funded research programs directed to finding treatments or a vaccine for COVID-19, the impact of COVID-19 on other scientific research has been difficult to assess.Certainly, a large amount of the impact has fallen on startups of all kinds, particularly technology-based startups.

Please sign in to continue.

Become a valued Chicago Lawyer subscriber today and receive:

Call (312) 644-2394 or subscribe now.